180 Epizód

  1. National asthma guidelines, bisoprolol for COPD and abaloparatide for osteoporosis

    Közzétéve: 2025. 07. 01.

  2. Identifying VTE in early pregnancy, gabapentinoids and COPD, managing ADHD

    Közzétéve: 2025. 06. 03.

  3. The polypill revisited, cytisinicline for vaping cessation and a new co-host

    Közzétéve: 2025. 05. 09.

  4. Misuse of female empowerment to sell tests and treatments, triptan safety, use of ACEI or AIIRA in CKD

    Közzétéve: 2025. 04. 02.

  5. Paying the price, liver problems with fezolinetant, systemic anticancer treatments

    Közzétéve: 2025. 03. 03.

  6. Prioritising shared decision making, remission from type 2 diabetes, gefapixant for cough

    Közzétéve: 2025. 01. 27.

  7. PILs: all harms and no benefits, Irish College of GPs end pharma funding, Ryeqo for fibroids

    Közzétéve: 2024. 12. 30.

  8. When it comes to drugs, sex matters; menopausal HT and dementia; daridorexant for sleep

    Közzétéve: 2024. 11. 28.

  9. Supporting obesity treatment, major bleeds with anticoagulants and SSRIs, equity in COPD care

    Közzétéve: 2024. 10. 30.

  10. (Un)common sense in oncology, DOACs in device-detected AF, and hypertension in the elderly

    Közzétéve: 2024. 09. 25.

  11. Medicines optimisation measures, warfarin-tramadol interaction and icosapent ethyl

    Közzétéve: 2024. 09. 06.

  12. Psychotropic medicines in children, warfarin vs DOAC in old age, and fezolinetant in menopause

    Közzétéve: 2024. 07. 29.

  13. Propranolol and its risk in overdose and managing COPD exacerbations

    Közzétéve: 2024. 07. 01.

  14. Diagnostic imaging and shielding, sinusitis, antibiotics and coloured snot, ritlecitinib

    Közzétéve: 2024. 05. 29.

  15. Medicines and global warming, donanemab for AD, and cytisine for smoking cessation

    Közzétéve: 2024. 04. 25.

  16. Drug safety alerts, valproate safety (again) and a new contraceptive POP

    Közzétéve: 2024. 03. 26.

  17. Protecting consumers, tramadol-warfarin interaction and very low calorie diets

    Közzétéve: 2024. 02. 28.

  18. ADHD medicines shortages, fluoroquinolone safety, drugs not to prescribe

    Közzétéve: 2024. 01. 30.

  19. Continuity of care, statins and myasthenia gravis, and acne

    Közzétéve: 2023. 12. 28.

  20. Rationalising blood tests, bempedoic acid and CV outcomes and semaglutide for obesity

    Közzétéve: 2023. 11. 30.

1 / 9

The Drug and Therapeutics Bulletin (DTB) Podcast is your source for practical, independent, and evidence-based information on drugs, medication, and prescribing. Join the Editor-in-Chief and Deputy Editor of DTB each month as they discuss the key highlights of the latest issue. DTB - dtb.bmj.com - is published by BMJ Group, and offers rigorous, independent evaluations and practical advice on treatments and disease management for doctors, pharmacists, and healthcare professionals. Subscribe to the DTB Podcast and get the latest drug and therapeutic insights. * The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.

Visit the podcast's native language site